B. Metzler seel. Sohn & Co’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-18,305
| Closed | -$1.53M | – | 770 |
|
|
2024
Q4 | $1.53M | Sell |
18,305
-14,986
| -45% | -$1.25M | 0.02% | 441 |
|
|
2024
Q3 | $2.44M | Buy |
33,291
+2,950
| +10% | +$216K | 0.02% | 342 |
|
|
2024
Q2 | $2.08M | Hold |
30,341
| – | – | 0.02% | 373 |
|
|
2024
Q1 | $2.1M | Buy |
30,341
+4,334
| +17% | +$300K | 0.02% | 377 |
|
|
2023
Q4 | $1.86M | Buy |
26,007
+374
| +1% | +$26.8K | 0.02% | 376 |
|
|
2023
Q3 | $1.34M | Sell |
25,633
-22,389
| -47% | -$1.17M | 0.02% | 403 |
|
|
2023
Q2 | $3.04M | Buy |
48,022
+20,412
| +74% | +$1.29M | 0.04% | 293 |
|
|
2023
Q1 | $1.5M | Sell |
27,610
-3,014
| -10% | -$163K | 0.02% | 369 |
|
|
2022
Q4 | $1.62M | Buy |
30,624
+2,137
| +8% | +$113K | 0.03% | 347 |
|
|
2022
Q3 | $1.33M | Buy |
28,487
+478
| +2% | +$22.3K | 0.02% | 375 |
|
|
2022
Q2 | $1.6M | Sell |
28,009
-7,422
| -21% | -$424K | 0.03% | 345 |
|
|
2022
Q1 | $2.17M | Buy |
35,431
+3,600
| +11% | +$220K | 0.03% | 326 |
|
|
2021
Q4 | $1.66M | Sell |
31,831
-10,629
| -25% | -$554K | 0.02% | 348 |
|
|
2021
Q3 | $1.58M | Buy |
42,460
+22,706
| +115% | +$847K | 0.02% | 353 |
|
|
2021
Q2 | $806K | Sell |
19,754
-2,391
| -11% | -$97.6K | 0.01% | 479 |
|
|
2021
Q1 | $751K | Buy |
22,145
+522
| +2% | +$17.7K | 0.01% | 475 |
|
|
2020
Q4 | $697K | Buy |
+21,623
| New | +$697K | 0.01% | 463 |
|